請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/96539完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 何耕宇 | zh_TW |
| dc.contributor.advisor | Keng-Yu Ho | en |
| dc.contributor.author | 魏群 | zh_TW |
| dc.contributor.author | Chun Wei | en |
| dc.date.accessioned | 2025-02-19T16:25:33Z | - |
| dc.date.available | 2025-02-20 | - |
| dc.date.copyright | 2025-02-19 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-01-17 | - |
| dc.identifier.citation | 一、中文文獻
TAIWAN BUSINESS TOPICSON (2021),裕利醫藥醫藥物流界的永續先鋒,https://topics.amcham.com.tw/2021/08/%E8%A3%95%E5%88%A9%E9%86%AB%E8%97%A5-%E9%86%AB%E8%97%A5%E7%89%A9%E6%B5%81%E7%95%8C%E7%9A%84%E6%B0%B8%E7%BA%8C%E5%85%88%E9%8B%92/ 江慧珺 (2021),疫苗冷鏈挑戰1/全台疫苗冷鏈配送使命必達到貨消息保密家,https://www.cna.com.tw/news/ahel/202110120044.aspx。 林庭安 (2023),市占逾 5成,營收居亞洲13間分公司之冠!裕利台灣做對了哪些事情?https://www.managertoday.com.tw/articles/view/67158?utm_source=copyshare。 劉越萍 (2023),醫療機構推動淨零排放政策與展望,https://www.hst.org.tw/uploads/ck_file/manage/files/02_%E9%86%AB%E7%99%82%E6%A9%9F%E6%A7%8B%E6%8E%A8%E5%8B%95%E6%B7%A8%E9%9B%B6%E6%8E%92%E6%94%BE%E6%94%BF%E7%AD%96%E8%88%87%E5%B1%95%E6%9C%9B.pdf。 二、英文文獻 Aaron Tan (2019), How Zuellig Pharma is Fighting Fake Drugs with Blockchain, https://www.computerweekly.com/news/252470429/How-Zuellig-Pharma-is-fighting-fake-drugs-with-blockchain. Abha Rustagi (2024), Zuellig-pharma Leads Green Transportation Initiative with Volvo FE Electric Truck, https://energetica-india.net/news/zuellig-pharma-leads-green-transportation-initiative-with-volvo-fe-electric-truck. Peggy Sito (2022), Zuellig Pharma’s Blockchain-based Tracking System Can Prevent Accidents Involving Expired Covid-19 vaccines, https://www.scmp.com/business/companies/article/3165046/zuellig-pharmas-blockchain-based-tracking-system-can-prevent. The EcoVadis Team (2024), Understanding-EcoVadis-Medals-and-Badges, https://support.ecovadis.com/hc/en-us/articles/210460227- Understanding-EcoVadis-Medals-and-Badges. Zuellig pharma, Zuellig Pharma Sustainability Report 2023, https://www.zuelligpharma.com/about-us/sustainability. Zuellig Pharma (2024), A Sustainable Approach to Healthcare Access Through Innovative Solutions, https://www.biospectrumasia.com/company-results/54/24990/zuellig-pharma-a-sustainable-approach-to-healthcare-access-through-innovative-solutions.html. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/96539 | - |
| dc.description.abstract | 醫藥物流業在新冠肺炎疫情和環境複雜變化下,面臨減碳壓力與公司治理深化的重大挑戰。醫藥物流業為醫療體系中關鍵的一環,其營運策略與背後上下游的全生命週期流程,對環境與社會有著重大影響。本論文以“Z醫藥物流服務公司”爲個案,探討醫藥物流業者在推動永續發展策略中所採取的ESG (環境、社會與公司治理)進展與績效。
本研究重點在評估Z公司對環境保護、社會責任與公司治理上的堅持,以及其嚴格定義全面永續發展目標。Z公司透過四大永續發展主題,包括友善環境、改善健康、人才發展以及設定正直作業標準,並針對每個主題列出目標、承諾及實績。 論文最終將重點決策改善自然環境,提高社會互信,並擴大醫療服務的可取得性,為國際醫藥物流業提供深入定義。結果顯示,Z公司連續四年的減碳指標和健康保障策略已展現出顯著維持效益。未來,建議持續深化四大永續支柱的實踐,並積極探索創新解決方案,如持續投資於數位科技、推動減碳行動、加強與利害關係人的合作,並提升企業道德和誠信標準以應對未來的挑戰。 | zh_TW |
| dc.description.abstract | The pharmaceutical logistics industry faces significant challenges in reducing carbon emissions and enhancing corporate governance amidst the COVID-19 pandemic and increasing environmental complexities. As a critical link in the healthcare system, its operational strategies and whole lifecycle processes have profoundly impacted the environment and society. This thesis focuses on "Z Pharmaceutical Logistics Service Company" as a case study to explore the advancements and outcomes of ESG (Environmental, Social, and Governance) strategies adopted by pharmaceutical logistics companies to promote sustainable development.
This study highlights Z Company’s commitment to environmental protection, social responsibility, and corporate governance, as well as its rigorous definition of comprehensive sustainability goals. Z Company has implemented four major sustainability pillars—respecting the environment, improving health outcomes, nurturing talent, and setting the highest standards of integrity—with specific targets, commitments, and results for each pillar. The thesis ultimately emphasizes decisions to improve the natural environment, enhance societal trust, and expand the accessibility of healthcare services, offering profound insights into the international pharmaceutical logistics industry. The results indicate that Z Company’s carbon reduction targets and health protection strategies have demonstrated significant sustainability benefits over four consecutive years. In the future, it recommends deepening the implementation of the four major sustainability pillars, actively exploring innovative solutions such as sustained investment in digital technology, advancing carbon reduction initiatives, strengthening collaborations with stakeholders, and enhancing corporate ethics and integrity standards to meet upcoming challenges. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-02-19T16:25:33Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-02-19T16:25:33Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 目次
口試委員會審定書 I 致謝 II 中文摘要 III THESIS ABSTRACT IV 目次 V 表次 VII 圖次 VIII 第一章 緒論 1 1.1 研究背景與動機 2 1.2 研究目的 3 1.3 研究範圍 4 1.4 研究內容 4 第二章 台灣醫藥物流產業 ESG 概況、挑戰及評級背景 6 2.1 台灣醫藥物流產業ESG概況 6 2.2 EcoVadis ESG社會責任評級背景介紹 11 第三章 ESG議題評估及個案公司選定 14 3.1 醫藥物流服務商個案介紹(Z公司) 14 3.2 Z公司ESG重大議題決定流程 16 3.3 Z公司ESG重大議題清單及選定 18 3.4 Z公司ESG 重要關係人及組織設定 20 3.5 Z公司ESG政策承諾 22 第四章 Z公司ESG執行的四大支柱 23 4.1 支柱一:友善環境 23 4.2 支柱二:改善健康 27 4.3 支柱三:人才發展 34 4.4 支柱四:設定誠信正直最高標準 36 4.5 小結 39 第五章 結論與建議 42 5.1 結論 42 5.2 建議 43 參考文獻 45 表次 表3-1:Z公司ESG重大議題矩陣-顧客面 17 表3-2:Z公司ESG重大議題矩陣-客戶面 17 表3-3:Z公司ESG重大議題矩陣-僱員面 18 表3-4:Z公司ESG重大議題清單 19 表4-1:Z公司友善環境實績26 表4-2:Z公司患者負擔能力實績 33 表4-3:Z公司改善當地社區參與與企業社會責任實績 33 圖次 圖1-1:英國NHS碳排放範疇1-3佔比分析 1 圖2-1:醫療服務提供者推動淨零碳排的7個面向 6 圖2-2:2014年國內醫療體系溫室氣體排放之範疇1-3佔比分析 7 圖3-1:Z公司在醫療供應鏈的角色 15 圖3-2:Z公司ESG重大議題決策流程 21 圖3-3:Z公司ESG管理組織 21 圖4-1:Z公司ESG執行的四大支柱 23 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 減碳策略 | zh_TW |
| dc.subject | 永續發展 | zh_TW |
| dc.subject | 醫藥物流 | zh_TW |
| dc.subject | Carbon Reduction Strategies | en |
| dc.subject | Pharmaceutical Logistics | en |
| dc.subject | Sustainability | en |
| dc.title | Z醫藥物流服務公司永續發展策略之探討 | zh_TW |
| dc.title | Research and Discussion on the Sustainable Development Strategy of Z Pharmaceutical Logistics Service Company | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-1 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 周冠男;柯冠成;張景宏 | zh_TW |
| dc.contributor.oralexamcommittee | Kuan-Nan Chou ;Kuan-Cheng Ko;Ching-Hung Chang | en |
| dc.subject.keyword | 醫藥物流,永續發展,減碳策略, | zh_TW |
| dc.subject.keyword | Pharmaceutical Logistics,Sustainability,Carbon Reduction Strategies, | en |
| dc.relation.page | 46 | - |
| dc.identifier.doi | 10.6342/NTU202500167 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2025-01-17 | - |
| dc.contributor.author-college | 管理學院 | - |
| dc.contributor.author-dept | 碩士在職專班財務金融組 | - |
| dc.date.embargo-lift | 2025-02-20 | - |
| 顯示於系所單位: | 財務金融組 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-1.pdf | 3.76 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
